Find Clinical Trial Information

Novartis clinical trials that are recruiting subjects in countries outside of the United States are posted on ClinicalTrials.gov which is a website service provided by the U.S. National Institutes of Health (NIH). The NIH, through its National Library of Medicine (NLM), has developed this website in collaboration with the Food and Drug Administration (FDA), as a result of the FDA Modernization Act, which was passed into law in November 1997.

Read Novartis clinical trials posted on ClinicalTrials.gov.

Or search ClinicalTrials.gov for information about other clinical trials seeking patient participation.

If you are a U.S. resident, please click here to read more information about the ongoing ENEST clinical trials seeking U.S. participants.



Disclaimer: This is intended for healthcare professionals. This is an international website for the ENEST (Evaluating Nilotinib Efficacy and Safety in Clinical Trials) program. The information on this site is not country-specific and may contain ENEST program information that is different from where you practice. Please contact your local Novartis representative for the latest ENEST information specific to your country. The compound NILOTINIB described in this site has been approved in a number of countries for Ph+ CML; it has not been approved in any countries for KIT+ GIST. If NILOTINIB has not yet been approved in your country, there is no guarantee that NILOTINIB will become commercially available.